GPT and fatty liver disease: In ameta-analysis of nine randomised trials with fatty liver disease, the probiotictherapy group has significant reduction in the levels of serum AST, ALT and totalcholesterol in comparison with the control group.109 In a study of 20 obesechildren who received Lactobacillus rhamnosus strain GG for8 weeks, there was an improvement in ALT in comparison with the controlgroup.110 Similar findings were demonstrated in a study of 64 obesechildren in addition to improvements in cholesterol, low-density lipoprotein-Ctriglycerides and waist circumference decrease.111